Prime Genomics: Robert Weigle
Oct 29, 2020
Prime Genomics, a company developing noninvasive testing to improve breast cancer detection, has named Robert Weigle as CEO. Weigle joins the firm from DigitalDx Ventures where he was an entrepreneur in residence. He has previously held senior-level sales and marketing positions at Johnson & Johnson, Baxter, and several startup ventures.